Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Samuelsson

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Lakartidningen|March 10, 2005
[New service for laboratory investigation of problematic cases. Four patients illustrate the value of EQUALIS]Göran Lindstedt, Samir Dzaferagic, Per Hansson, et al.
BMJ (Clinical Research Ed.)|July 17, 1998
Survival in treated hypertension: follow up study after two decadesO K Andersson, T Almgren, B Persson, et al.
Kidney International|March 31, 2006
Effect of fluvastatin on apolipoprotein-defined lipoprotein subclasses in patients with chronic renal insufficiencyP Alaupovic, P-O Attman, C Knight-Gibson, et al.
Journal of Hypertension|April 1, 1985
Predictors of cardiovascular morbidity in treated hypertension: results from the primary preventive trial in Göteborg, SwedenO Samuelsson, L Wilhelmsen, D Elmfeldt, et al.
BMJ (Clinical Research Ed.)|January 1, 1994
Dyspnoea, asthma, and bronchospasm in relation to treatment with angiotensin converting enzyme inhibitorsH Lunde, T Hedner, O Samuelsson, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 23, 2000
Angiotensin I-converting enzyme gene polymorphism in non-diabetic renal diseaseO Samuelsson, P O Attman, R Larsson, et al.
Lakartidningen|April 29, 1998
[Is antihypertensive treatment a risk factor of coronary disease? Therapy-related triglyceride increase nor diabetes increase the risk]O Samuelsson, K Pennert, O Andersson, et al.
BMJ (Clinical Research Ed.)|September 14, 1996
Diabetes mellitus and raised serum triglyceride concentration in treated hypertension--are they of prognostic importance? Observational studyO Samuelsson, K Pennert, O Andersson, et al.
Mineral and Electrolyte Metabolism|February 22, 2000
Apolipoprotein C-III, hypertriglyceridemia and triglyceride-rich lipoproteins in uremiaJ B Moberly, P O Attman, O Samuelsson, et al.
Journal of the American Society of Nephrology : JASN|August 11, 1998
Complex apolipoprotein B-containing lipoprotein particles are associated with a higher rate of progression of human chronic renal insufficiencyO Samuelsson, P O Attman, C Knight-Gibson, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Lakartidningen|March 10, 2005
[New service for laboratory investigation of problematic cases. Four patients illustrate the value of EQUALIS]Göran Lindstedt, Samir Dzaferagic, Per Hansson, et al.
BMJ (Clinical Research Ed.)|July 17, 1998
Survival in treated hypertension: follow up study after two decadesO K Andersson, T Almgren, B Persson, et al.
Kidney International|March 31, 2006
Effect of fluvastatin on apolipoprotein-defined lipoprotein subclasses in patients with chronic renal insufficiencyP Alaupovic, P-O Attman, C Knight-Gibson, et al.
Journal of Hypertension|April 1, 1985
Predictors of cardiovascular morbidity in treated hypertension: results from the primary preventive trial in Göteborg, SwedenO Samuelsson, L Wilhelmsen, D Elmfeldt, et al.
BMJ (Clinical Research Ed.)|January 1, 1994
Dyspnoea, asthma, and bronchospasm in relation to treatment with angiotensin converting enzyme inhibitorsH Lunde, T Hedner, O Samuelsson, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 23, 2000
Angiotensin I-converting enzyme gene polymorphism in non-diabetic renal diseaseO Samuelsson, P O Attman, R Larsson, et al.
Lakartidningen|April 29, 1998
[Is antihypertensive treatment a risk factor of coronary disease? Therapy-related triglyceride increase nor diabetes increase the risk]O Samuelsson, K Pennert, O Andersson, et al.
BMJ (Clinical Research Ed.)|September 14, 1996
Diabetes mellitus and raised serum triglyceride concentration in treated hypertension--are they of prognostic importance? Observational studyO Samuelsson, K Pennert, O Andersson, et al.
Mineral and Electrolyte Metabolism|February 22, 2000
Apolipoprotein C-III, hypertriglyceridemia and triglyceride-rich lipoproteins in uremiaJ B Moberly, P O Attman, O Samuelsson, et al.
Journal of the American Society of Nephrology : JASN|August 11, 1998
Complex apolipoprotein B-containing lipoprotein particles are associated with a higher rate of progression of human chronic renal insufficiencyO Samuelsson, P O Attman, C Knight-Gibson, et al.
Pageof 6